As the global healthcare system accelerates its acceptance of gene therapies as one-time, potentially curative, treatment options for rare diseases, the role of patient engagement in informing drug development strategy is evolving. At this interface lies the 3rd Gene Therapy Patient Engagement Summit, uniting patient advocacy and engagement experts from leading gene therapy and gene […]

Advance your end-to-end logistics strategy to deliver vital therapeutics at the RIGHT TIME, RIGHT PLACE and the RIGHT TEMPERATURE Join us in Frankfurt in June 2023 in a brand-new venue at the heart of Europe, as once again, we return live and in-person for 3 days of interactive sessions, collaborative roundtables as well as formal and informal networking to maximise the […]

Returning for the 3rd year, the ILD Summit will lean into the industry’s key challenges, explore pipeline opportunity development, and look towards the future for ILD therapeutic development from idiopathic pulmonary fibrosis pipelines. From illuminating predictors of progression to define and identify the progressive fibrosis phenotypes for patient stratification to evolving clinical trial design with novel secondary and exploratory endpoints beyond FVC. This is a fantastic point in […]

With exciting developments in pioneering inhaled drug products from Moderna, Vertex, ReCode Therapeutics, and Pieris Pharmaceuticals, now is the time to go full speed ahead on your efforts into inhaled formulation and delivery optimization. Despite the inhalation drug delivery market being expected to reach $18.6 billion by 2029, achieving cell-specific delivery, and optimized stability remain vital challenges. This […]

Exciting results are expected this year, from multiple mid and late stage clinical trials and involving a broad array of adenosine drugs including CD73, CD39 and A2AR! To ensure the community can capitalize on this, the 2nd Annual Adenosine-Pathway Targeted Cancer Immunotherapy Summit will be returning this June (20 – 22) in Boston, MA – dedicated to […]

This event will take place in London on 21-22 June 2023 in London, focusing on the three biggest priorities enabling growth in the AMR field - Innovation, Investment & Policy - AMR Connect enables you to foster connections with key stakeholders in anti-microbial research and build actionable next steps to combat the silent pandemic. AMR […]

As the biggest industry-led meeting on novel vector development, the 3rd Annual Next Generation Gene Therapy Vectors Summit (June 27-29, 2023 | Boston, MA) will bring together 100+ key opinion leaders to help solve the safety, efficiency, and scalability challenges of the next generation of vectors. Industry heavyweights such as Novartis, Spark Therapeutics, Capsida Biotherapeutics, […]

The 8th Microbiome Movement Drug Development Summit returns in 2023 as North America's definitive microbiome drug development event - and it's back bigger and better than ever! The microbiome-based therapeutic market is rapidly evolving, and it's more important than ever to showcase the efficacy of microbial-based approaches beyond C. difficile. Discover how drug developers are […]

CNS biopharma is rapidly investing in digital technologies to revolutionize clinical identification and monitoring of complex neurological disorders through more objective, frequent, sensitive, and less invasive measures of movement, speech, and cognition. Returning to Boston, the 2nd Digital Biomarkers & Clinical Measures in Neurology Summit is the only industry-specific meeting dedicated to developing translatable, scalable, and successful digital […]

With more than 300 trials in preclinical and clinical development actively using AAV as their vector of choice, the priority for any company working in this space is to ensure that each and every one of those therapies is the safest version it can be. In this context, the 2nd Annual Optimizing AAV Safety Summit […]

The Advanced Wound Care Summit is wound care’s only industry-led forum It’s a chance for senior executives to address shared challenges around innovative product development, build meaningful partnerships, and sharpen their R&D and commercial strategies. Whether an established wound care company, an emerging startup, an SME, a regulator, a payer, or key opinion leader, this […]

The 3rd Annual Tumor Myeloid-Directed Therapies Summit returns with over 75% new speakers to share insights across a range of myeloid targets, including CD40, CD39, LILRB2, CLEC-1 as well as CAR-M therapies. The one-stop shop continues to be your go-to forum to accelerate myeloid therapy progression by determining optimal combination strategy, optimize translational studies, discover […]

There is a vast number of ADCs that never make it to the clinic let alone to market, and this is largely due to toxicological challenges providing a narrow therapeutic index. Understanding the causes of toxicity, their translatability into the clinic, as well as mitigation and dosing strategies to limit these toxicities will enable ADC […]

With the exciting news that Novartis has received US FDA approval for Pluvicto for previously-treated patients with PSMA-positive metastatic castration-resistant prostate cancer, the TRP space is continuing to go from strength to strength. This is why the upcoming 2nd Annual Targeted Radiopharmaceuticals Summit US program is even more comprehensive than ever, bringing you a tracked agenda covering the whole TRP landscape from discovery, translation, to clinical, late stage progress and challenges – a unique opportunity for […]

Design & Engineer Functional & Manufacturable Novel Fusion Proteins Prepare to be captivated by the Fusion Protein Engineering & Developability Summit, the ultimate event tailored to drug developers with groundbreaking fusion protein pipelines. This conference is an absolute game-changer that should be at the top of your priority list! As the demand for practical and […]

Established industry leaders and emerging innovators such as Adicet Bio, IN8Bio, Sanofi, Merck, LAVA Therapeutics, Takeda and Leucid Bio are driving the race to demonstrate the potential of Gamma Delta T Therapies as cytotoxic, off-the-shelf solid tumor therapies, spurred by early indications of clinical efficacy. The 4th Gamma Delta T Therapies Summit returns to Boston […]

The 3rd mRNA-Based Therapeutics Summit returns to Boston this July, cementing its position as the world’s only end-to-end meeting focused on the next generation of mRNA-based therapeutics and vaccines. Download the event program here. This year’s meeting promises 75+ deep-dive case studies from a speaker faculty that is 85% new for this year’s agenda, featuring presentations from the FDA, Pfizer, Moderna, BioNTech, Sanofi and many more. Expect 100+ […]

Investments in linker and conjugation technologies have become the single-biggest area of investments within the ADC field, showing how they are being used as key levers for ADC drug developers to pull to create ADCs with a widened therapeutic index. The inaugural ADC Linker & Conjugation Summit has been specifically designed to drive innovations in […]

Bringing together technical experts from biopharma and academia, the brand-new RNA Assay Development & Screening Summit has been curated to support in-house assay development and screening strategies to find new RNA targets, and ultimately determine biological effect in a manner that supports progression from early discovery to drug candidate. Developed in collaboration with experts in the field, join 60+ […]

Last year was momentous for the cell therapy field: it was the year that CAR-T therapies became CURATIVE. This decade of success has resulted in explosive investment into the development of CAR and TCR based approaches to ensure more patients around the world can benefit from these lifesaving therapies.   The 8th CAR-TCR Summit is returning to Boston as […]

Rapid development and rising demand of oligonucleotide drugs is fuelling revolutionary steps in biopharma investment and technology advancement for pipeline progression. The prospect of defining impurities and suitable CQAs for long-term scalable manufacturing looks to propel oligonucleotide development to patients at a much faster rate. The 2nd Oligonucleotides CMC & Analytical Development Summit returns this […]

The development of next-generation drug-based approaches to treat inner ear disorders is gaining momentum, with multiple INDs approved in the last six months and big pharma making plays to acquire innovative biotechs working on hearing loss. However, in a space that has also had to battle with multiple clinical failures, there’s a genuine need for […]

The 5th Exosome Based Therapeutic Development Summit returns with a refreshed program, with data-driven insights from those pioneering the field who are dedicated to the clinical translation and commercialization of exosome-based therapeutics across a broad range of disease indications. This year features a brand-new focus day on analytical development, diving into characterization assays, purification, and […]

The 4th Annual Gene Therapy Immunogenicity Summit is your opportunity to connect with likeminded peers from gene therapy drug developers, along with leading academics, regulators, and key service providers, all making strides with improving risk assessments, monitoring, and mitigating against AAV gene therapy immunogenicity. Registering for 2023 will grant you access to keynote plenaries from […]

The hotly anticipated 13th World Clinical Biomarkers & CDx Summit returns as the only industry-led meeting uniting 600+ senior decision makers in the biomarker and CDx field to accelerate clinically validated and affordable co-development of drug-CDx by overcoming commercialization, reimbursement and regulatory challenges in oncology and beyond to bring personalized medicine to patients faster. Whether […]

With the recent FDA approval of SYFOVRE and more decisions and approvals expected in 2023, the Complement-Based Drug Development Summit is returning for its 7th year in a timely fashion. Be the first to view this year’s Event Guide below! 7th Complement-Based Drug Development Summit September 11-13, 2023 View Agenda Reuniting experts across Nephrology, Neurology, Ophthalmology, and Haematology, join the leading companies showcasing the […]

Fingerprinting Your LNP Drug Product Quality, Safety, Efficacy & Regulatory Compliance With the recent breakthroughs from Verve Therapeutics, Vertex-Arbor Bio, and Mana.bio propelling the field of LNP technology forward at lightning speed beyond mRNA vaccines, the LNP Characterization & Analytical Development Summit is your must-attend meeting to deep dive into the latest technologies and approaches throughout product lifecycle and […]

Your one-stop shop to capturing industry’s most exciting developments to tackle rare & genetic kidney diseases. From evaluating real-world outcomes to uncovering underlying pathophysiology to interrogating translational models, the 3rd Rare & Genetic Kidney Disease Drug Development Summit is uniquely positioned to give industry the opportunity to unite towards a shared goal and share strategic […]

Wearable Injectors and Connected Devices USA Conference: September, 13 – 14 2023 Boston, USA Website: http://www.wearableinjectors-usa.com/PharmaJournalist-EL Advancing digital health and on-body drug delivery devices for enhanced patient experience Following the success of the Wearable Injectors and Connected Devices Europe conference, SAE Media Group will be bringing the conference to Boston to cater to Big Pharma, […]

FIbroGen’s recent Phase 3 trial failure for pamrevlumab exemplifies the critical time point the pulmonary fibrosis field is currently at as drug developers move through in-human to Phase 2 to Phase 3 trials to get the next disease-modifying drug to the patients in need. The 7th IPF Summit (September 19-21 | Boston) returns at this crucial stage for […]